Neurological Immune-Related Adverse Events of Ipilimumab
Pract Neurol 13:278-280, Bot, I.,et al, 2013
In Patients with Melanoma Brain Metastases, is Combination Immune Checkpoint Inhibition a Safe and Effective First-Line Treatment? A Critically Appraised Topic
Neurologist 27:290-297, Gritsch, D.,et al, 2022
Horizontal Diplopia Due to Extraocular Muscle Metastasis
Neurol 99:669-670, Atik, M.,et al, 2022
Autoimmune Encephalitis Related to Cancer Treatment with Immune Checkpoint Inhibitors
Neurol 97:e191-e202, Nersesjan, V.,et al, 2021
Association of Innovations in Radiotherapy and Systemic Treatments with Clinical Outcomes in Patients with Melanoma Brain Metastasis From 2007 to 2016
JAMA doi:10.1001/JAMANETWORKOPEN.2020.8204, Brastianos, H.C.,et al, 2020
Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
NEJM 379:722-730,789, Tawbi, H.A.,et al, 2018
Human Natural Autoantibodies in the Treatment of Neurologic Disease
Neurol 72:1269-1276, Rodriguez,M.,et al, 2009
Surgical Treatment for Renal Cancer Metastases
Actas Urol Esp 33:593-602, Ruiz-Cerda, J.L. & Jimenez Cruz, F., 2009
Bilateral Extraocular Muscle Metastasis From Primary Breast Cancer
Neurol 65:74-75, Peckham,E.L.,et al, 2005
CNS Mycosis Fungoides:CT and MR Findings
J Comput Assist Tomogr 16:529-533, Tein,R.D.,et al, 1992
Neurologic Complications of Carcinoid
Neurol 36:745-749, Parchell,R.A.&Posner,J.B., 1986
Spastic Pure Motor Monoparesis
Ann Neurol 20:638-641, Ashizawa,T.,et al, 1986
Case Records of the MGH
Metastatic Choreocarcinoma from Ovary, NEJM 296:9261977., , 1977